Next Article in Journal
Phytotoxic Activity of Metabolites Isolated from Rutstroemia sp.n., the Causal Agent of Bleach Blonde Syndrome on Cheatgrass (Bromus tectorum)
Next Article in Special Issue
Comprehensive Snake Venomics of the Okinawa Habu Pit Viper, Protobothrops flavoviridis, by Complementary Mass Spectrometry-Guided Approaches
Previous Article in Journal
The Cartesian Product and Join Graphs on Edge-Version Atom-Bond Connectivity and Geometric Arithmetic Indices
Previous Article in Special Issue
A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria
Open AccessReview

The Biological and Biophysical Properties of the Spider Peptide Gomesin

School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute and Curtin Institute for Computation, Curtin University, GPO Box U1987, Perth WA 6845, Australia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2018, 23(7), 1733; https://doi.org/10.3390/molecules23071733
Received: 1 July 2018 / Revised: 11 July 2018 / Accepted: 12 July 2018 / Published: 16 July 2018
This review summarises the current knowledge of Gomesin (Gm), an 18-residue long, cationic anti-microbial peptide originally isolated from the haemocytes of the Brazilian tarantula Acanthoscurria gomesiana. The peptide shows potent cytotoxic activity against clinically relevant microbes including Gram-positive and Gram-negative bacteria, fungi, and parasites. In addition, Gm shows in-vitro and in-vivo anti-cancer activities against several human and murine cancers. The peptide exerts its cytotoxic activity by permeabilising cell membranes, but the underlying molecular mechanism of action is still unclear. Due to its potential as a therapeutic agent, the structure and membrane-binding properties, as well as the leakage and cytotoxic activities of Gm have been studied using a range of techniques. This review provides a summary of these studies, with a particular focus on biophysical characterisation studies of peptide variants that have attempted to establish a structure-activity relationship. Future studies are still needed to rationalise the binding affinity and cell-type-specific selectivity of Gm and its variants, while more pre-clinical studies are required to develop Gm into a therapeutically useful peptide. View Full-Text
Keywords: toxins; peptides; spider peptides; peptide-membrane interactions; anti-microbial peptides; anti-cancer peptides; structure-activity relationship; rational drug design toxins; peptides; spider peptides; peptide-membrane interactions; anti-microbial peptides; anti-cancer peptides; structure-activity relationship; rational drug design
Show Figures

Graphical abstract

MDPI and ACS Style

Tanner, J.D.; Deplazes, E.; Mancera, R.L. The Biological and Biophysical Properties of the Spider Peptide Gomesin. Molecules 2018, 23, 1733.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop